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ABSTRACT 
Objective: This study aims to evaluate the in vitro antioxidant, anti-inflammatory activities of the aqueous and hydroethanolic extracts recipe of 
Alchornea cordifolia and Antrocaryon klaineanum. A preliminary phytochemical screening was carried out.  
Methods: The total phenols content was determined by the Folin Ciocalteu reagent method, while the antioxidant activity of both extracts was 
characterized by the 2-2diphenyl-1-picrilhidrazil (DPPH) and β-carotene assays. The anti-inflammatory activity of the extracts was evaluated as the 
inhibition of Bovine Serum Albumin (BSA) denaturation and antiproteinase activity.  
Results: The aqueous extracts of Alchornea cordifolia and Antrocaryon klaineanum contained more polyphenols [270 mg Ascorbic acid equivalent 
(AAE)/g dry weight (dw)] than the hydroethanolic recipe extract (262.41 mg AAE/g dw) at the same concentration level. On the other hand, the 
aqueous and hydroethanolic recipe extract had the same radical scavenging activity with the antiradical power of 0.851 and 0.830, respectively. 
Similarly, the recipe extract had the same reducing activity with reducing the power of 94.2±2.03 mg EAA/g dw and 97.4±4.16 mg EAA/g dw for the 
aqueous and hydroethanolic recipe extract of Alchornea cordifolia and Antrocaryon klaineanum respectively. For the anti-inflammatory activity it 
was observed that both extracts possess the same activity as Diclofenac® with an IC50 of 50.21 μg/ml. The phytochemical screening of the extracts 
revealed the presence of alkaloids, flavonoids, carbohydrates, phenols and tannins, which may account for their activities.  
Conclusion: The plant recipe extract studied possess antioxidant and anti-inflammatory potentials, which may be beneficiary to its consumers. 
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INTRODUCTION 
Free radicals are known as Reactive Oxygen Species (ROS) are 
produced by the human body in a normal metabolic process and its 
environ. There is a permanent system of antioxidant defense of the 
body against ROS but, an imbalance between antioxidants and pro-
oxidants in favor of pro-oxidants leads to oxidative stress [1]. 
Oxidative stress and inflammation are strongly linked [2, 3]. 
Inflammation, when it reacts disproportionately, it may be 
inappropriate, pathological and altering homeostasis thus, 
contributing to the onset of disease [4]. The synthetic anti-
inflammatories and antioxidants currently used are associated with 
serious side effects like weight gain, gastric irritation [5]. Therefore, 
the development of anti-inflammatory drugs with little or no side 
effects is needed from medicinal plants. Alchornea cordifolia 
(Schumach. and Thonn.) Müll. Arg (Euphorbiaceae), also called “aboe” 
in ewondo, “dibobondji” in Douala, is one of such plants which is widely 
distributed in tropical and subtropical regions of Africa. In the central 
and coastal regions of Cameroon, Dibong et al. [6] reported that the 
leaves of this plant are used for the treatment of anemia. This plant has 
many order traditional applications, including treatment of pain and 
inflammatory disorders, hormonal-related gynecological disorders, 
infertility, urinary, respiratory and intestinal problems as well as 
malaria-like fevers and anti-HIV1 integrase activity [7-16]. Earlier 
studies on the chemical constituents of A. cordifolia identified 
compounds such as tannins, phenolic acids, flavonoids and alkaloids 
[11]. The varied popular uses of different parts of A. cordifolia have led 
to many modern pharmacological investigations like antibacterial 
[16], antifungal [17], spasmolytic [18] and reproductive activities [13]. 
Antrocaryon klaineanum Pierre (Anacardiaceae) called “angongui” in 
ewondo, “ngonga” in bassa is an evergreen tree, deciduous, medium-
sized up to 35 to 45 m tall [19]. The barks of Antrocaryon klaineanum 
are used as a decoction for the treatment of painful periods, sales 
ailments and even sexually transmitted infections in Cameroon [6]. 
The crude extract and the isolated compounds of this plant were 
evaluated for their ability to inhibit the 3D7 strain of Plasmodium 
falciparum and were evaluated to treat liver complaints and to 
facilitate the production of breast milk [20, 21]. Phytochemical studies 
of A. klaineanum extracts have shown the presence of secondary 
metabolites with antimalarial properties [22]. As of now, very few 
authors reported the evaluation of the antioxidant and anti-
inflammatory activities of the recipe from these plant. Therefore, the 
aim of the present study was to evaluate the antioxidant and anti-
inflammatory activities of the aqueous and hydroethanolic extracts 
recipe of Alchornea cordifolia (Schumach and Thonn.) Müll. Arg. and 
Antrocaryon klaineanum Pierre. 
MATERIALS AND METHODS  
Plant extracts 
The leaves of Alchornea cordifolia were collected in the locality of 
Mfou Center Region of Cameroon in July 2017. The plant 
identification was done at the Cameroon National Herbarium by 
comparison with specimen number 9657/SRF/Cam of Alchornea 
cordifolia (Schumach and Thonn.) Müll. Arg. (Euphorbiaceae). 
The barks of Antrocaryon klaineanum were collected in July 2017, in 
Ebolowa (Southern Region of Cameroon). The plant identification 
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was done at the Cameroon National Herbarium by comparison with 
specimen number 1742/SRF/Cam of Antrocaryon klaineanum Pierre 
(Anacardiaceae). 
The fresh vegetal material collected was dried in the shade at room 
temperature (25 °C) for two weeks to constant weight. The aqueous 
extracts were prepared by boiling 100 mg of plant material in 1000 ml of 
water. The hydro-ethanol extract was obtained from a maceration of 100 
g of plant material in 1000 ml of water-ethanol (70:30). 
The boiled extracts obtained was allowed to cool and then filtered 
using a 0.23 mm diameter filter. The filtrate is then left on the bench 
for 24 h and the supernatant dried in a lyophilizer. 
The macerate obtained is filtered on hydrophilic cotton and then on 
Wattman No. 1 paper, then the filtrate is dried in an oven at 70 °C for 
48 h. The dried extracts obtained were weighed and stored in the 
refrigerator at 4 °C. 
As indicated in an ethnobotanical study, Alchornea cordifolia and 
Antrocaryon klaineanum are the most plants used in the treatment of 
infectious diseases in four cities of Cameroon as reported by Ndjib et 
al. [23]. For the preparation of the recipe solutions from the 
obtained plant extracts, the same amount of mass of each extract is 
weighed and solubilized in sterile distilled water to obtain a final 
concentration of 100 mg/ml [24]. 
Determination of the total phenols content by the Folin-
Ciocalteu method 
The total polyphenols were evaluated according to the 
spectrophotometric method using the Folin-Ciocalteu reagent as 
described by Chew et al. [25]. In this method, 1817 μl of distilled 
water was introduced into the test tube, 115 μl of Folin Ciocalteu 
diluted 1:10 and 345 μl of 15% sodium carbonate (Na2CO3) were 
added. Tubes were vortexed and incubated for 2 h, and the 
absorbance measured at 765 nm. Calibration was performed using a 
freshly prepared aqueous solution of Ascorbic acid. 
DPPH radical scavenging test 
The molecule of 1,1-diphenyl-2-picrylhydrazyl (DPPH) is characterized 
as a stable free radical by virtue of the delocalization of the spare 
electron over the molecule as a whole, so that the molecule does not 
dimerize, as would be the case with most other free radicals. To prepare 
a standard solution of 1,1-diphenyl-2-picrilhidrazil (DPPH°), 10 mg of 
DPPH was dissolved in 25 ml of methanol [26]. From this solution, 5 ml 
was taken and mixed with 45 ml of methanol. After preparing the 
different solutions, 1950 µl of the DPPH solution was pipetted into test 
tubes and 50 µl of each extract at different concentrations was then 
added to each test tube to a final volume of 2 ml per tube. All tests were 
carried out in triplicate in a dark room. The optical density was 
measured at a wavelength of 515 nm using a spectrophotometer of the 
brand Jenway 6305, Germany, after 120 min of incubation. 
Kinetic study, development of study conditions 
At the beginning of this evaluation, a kinetic study of the reactivity of 
DPPH with the different extracts recipe was carried out. It consisted 
in monitoring the reactivity of the DPPH over time by measuring the 
absorbance every 15 min for 120 min [27]. 
β-carotene bleaching coupled the auto-oxidation of linoleic acid 
assay 
The reductive capacity of extracts was estimated by the method [27] 
as described previously by Moure et al. [28] and Djova et al. [29]. 
Anti-inflammatory assays 
Bovine serum albumin (BSA) denaturation assay  
Protein denaturation was performed as described by Djova et al. 
[30]. 
Proteinase inhibitory action 
The anti-proteinase activity of ASE was determined using the 
Oyedepo and Famurewa method [31] with slight modifications. 
The reaction mixture (2 ml) was containing 0.06 mg trypsin, 1 ml 
of 20 mmol Tris HCl buffer (pH 7.4) and 1 ml test sample of 
different concentrations. The reaction mixture was incubated at 37 
°C for 5 min and then 1 ml of 5% (W/V) casein was added. The 
mixture was incubated for an additional 20 min, 2 ml of 70% 
perchloric acid was added to terminate the reaction. Cloudy 
suspension was centrifuged and the absorbance of the supernatant 
was read at 210 nm against buffer as blank. The experiment was 
performed in triplicate.  
Chemical screening 
The secondary metabolites present in the plant extracts studied 
were investigated through several methods that differ in their 
reagents and solvents as well as in the coloration observed and their 
presence was noted (+) and their absence (-) [32].  
Data analysis  
Graphs were obtained using the Microsoft Excel 2013 Spreadsheet. 
Statistical analyzes were performed in GraphPad/Prism 7 for 
Windows (San Diego, California, USA) and ANOVA Windows SPSS 23 
software. The analysis of the variance (ANOVA) was used to 
compare the averages between more than two groups. The 
materiality threshold was set at p<0.05.  
RESULTS 
Total phenolic content  
The evaluation of the total phenolic content in the extracts made it 
possible to quantify them in two categories of antioxidants as shown 
in table 1. 
 
Table 1: Total polyphenol content of a mixture of aqueous and hydroethanolic extracts 
Extracts 
 
Total phenols Primary antioxidants Secondary antioxidants  
(mg EAA/g dw) (mg EAA/g dw)  (mg EAA/g dw)  
 (Ac1+Ak1) 270.8±0.1** 8.33± 0.34* 94.2±2.03* 
(Ac2+Ak2) 262.41±0.3** 8.49± 0.3* 97.4±4.16* 
Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts Alchornea 
cordifolia and Antrocaryon klaineanum (v/v). Values that have the same symbols are statistically identical (*p ˃0.05). Statiscaly differences between 
total polyphenols content of combined aqueous and hydroethanolic extracts of Alchornea cordifolia and Antrocaryon klaineanum (**p˂0.001). 
 
In this table, it can be seen that the aqueous extract (270.8±0.1 
mg AAE/g dw) composed of extracts of equal proportions of 
Alchornea cordifolia and Antrocaryon klaneanum, had a higher 
total phenolic content than the hydroethanolic extract 
(262.41±0.3 mg AAE/g dw) composed of extracts of same 
proportion of the same plants. It was also noted that the extracts 
had a higher amount of preventive antioxidant with the content 
of 94.2±2.03 mg AAE/g dw and 97.4±4.16 mg AAE/g dw 
respectively for the combined aqueous extract of Alchornea 
cordifolia and Antrocaryon klaineanum and combined 
hydroethanolic extract of Alchornea cordifolia and Antrocaryon 
klaineanum than that of the curative antioxidant (8.33± 0.34 mg 
AAE/g dw and 8.49± 0.3 mg AAE/g dw) respectively for the 
combined aqueous extract of Alchornea cordifolia and 
Antrocaryon klaineanum and combined hydroethanolic extract of 
Alchornea cordifolia and Antrocaryon klaineanum. 
Kinetics of DPPH scavenging 
A kinetic study preceded the antiradical analysis by the DPPH 
method (fig. 1): 
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Fig. 1: Absorbance curves of the extracts as a function of time 
 
Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and 
Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts 
Alchornea cordifolia and Antrocaryon klaineanum (v/v) 
It follows from this curve that the decay of the kinetics curve of the 
DPPH continues until the 120th min and its stationary state is still 
not reached. 
DPPH antiradical assay 
The Ascorbic acid calibration curve for the DPPH test obtained is 
shown in fig. 2 below: 
This curve made it possible to obtain the concentration value for 
trapping 50% of free radicals (SC50) of Ascorbic acid, which is 
0.015±0.000 mg/ml. 
The following curve represents the percentage of free radical 
trapping by the extracts as a function of the concentration (fig.3): 
This curve made it possible to obtain the concentrations at which the 
extracts trap 50% of free radicals (SC50) from which the effective 
concentrations and the antioxidant power were deduced. The values 
obtained are recorded in the following table 2. 
  
 
Fig. 2: Ascorbic acid calibration curve for DPPH 
 
 
Fig. 3: Curves of the percentages of trapping of free radicals by the extracts, Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and 
Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v) 
 
Table 2: Anti-free radical efficacy of DPPH by extracts compared to ascorbic acid 
Extracts SC50 en mg/ml EC50 PA 
Aqueous extract (Ac1+Ak1) 0.47±0.2725* 1.175* 0.851* 
Hydroethanolic extract (Ac2+Ak2) 0.048±0.8143 1.2* 0.83* 
Ascorbic Acid 0.015± 0.000 0.375 2.66 
Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts Alchornea 
cordifolia and Antrocaryon klaineanum (v/v). Values that have the same symbols are statistically identical (*p ˃0.05). 
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The two extracts had substantially the same antiradical activity with 
statistically identical power of 0.81 and 0.851 respectively for the 
aqueous and hydroethanolic extracts of Alchornea cordifolia and 
Antrocaryon klaineanum, but Ascorbic acid with antiradical power of 
2.66 had a antiradical activity greater than that of the two extract 
plants.  
β-carotene bleaching assay 
The fig. 4 represents the reducing capacity of the aqueous and 
hydroethanolic extracts by the β-carotene method 
This curve made it possible to obtain the IC50 and reducing power 
values and the values are recorded in the following table 3: 
 
 
Fig. 4: Curve of the percentages of entrapments as a function of the concentration of the extracts 
Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts 
Alchornea cordifolia and Antrocaryon klaineanum (v/v) 
 
Table 3: Reductive capacity of in vitro extracts by the β-carotene test 
Extracts       µg/ml PR mg EAA/g dw 
Aqueous (AC1+Ak1) 2.64±0.11* 94.2±2.03* 
Hydroethanolic (Ac2+Ak2)  2.86±0.0655* 97.4±4.16* 
Ascorbic Acid 0.53±0.0053  
Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts Alchornea 
cordifolia and Antrocaryon klaineanum (v/v). Values that have the same symbols are statistically identical (*p ˃0.05). 
 
Extracts and Ascorbic Acid have statistically different reducing 
capacities at p = 0.0001 ˂ 0.005. Indeed, the reducing capacity of 
Ascorbic Acid (0.53±0.0053 μg/ml) is higher than that of the two 
recipes of aqueous and hydroethanolic extracts (between 2.64±0.11 
and 2.86±0.0655 μg/ml) respectively. In addition, the reducing 
capacity of the recipe composed of same proportions of aqueous 
extracts of Alchornea cordifolia and Antrocaryon klaineanum 
(2.64±0.11 μg/ml) is greater than that of the hydroethanolic extracts 
of the same plants (2.86±0.0655 μg/ml). 
Anti-inflammatory assay 
The fig. 5 below shows the curve of the percent inhibition as a 
function of the concentration of the aqueous (Alchornea cordifolia 
and Antrocaryon klaineanum, v/v) and the hydroethanolic 
(Alchornea cordifolia and Antrocaryon klaineanum, v/v) extracts 
compared to the anti-inflammatory reference, Diclofenac®: 
The IC50 was determined from the regression line Y = ax+b.  
The denaturation test of BSA reveals that the two extracts studied 
have substantially the same activity as Diclofenac at p<0.05 with an 
IC50 of 50.21 μg/ml. 
The fig. 6 shows percentage inhibition of proteinase extracts and 
acetylsalicylic acid versus concentration. 
This curve made it possible to determine the IC50 and the results 
recorded in the following table 4: 
 
 
Fig. 5: Calibration curve of the extracts and Diclofenac and capacity to denature the BSA 
Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanol extracts 
Alchornea cordifolia and Antrocaryon klaineanum (v/v) 
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Fig. 6: Curves showing percentages of proteinase inhibition by extracts 
Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanol extracts 
Alchornea cordifolia and Antrocaryon klaineanum (v/v) 
 
Table 4: Percentage inhibition of proteinase by extracts and acetylsalicylic acid 
Echantillons IC50 en µg/ml  
Aqueous Extract (Ac1+Ak1) 60±1.52* 
Hydroethanolic Extract (Ac2+Ak2) 75±2.08* 
Ascorbic Acid 10±0.57 
Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanol extracts Alchornea cordifolia 
and Antrocaryon klaineanum (v/v). Values that have the same symbols are statistically identical (*p ˃0.05). 
 
The IC50 values obtained vary from 10±0.57 μg/ml for Acetylsalicylic 
acid to 60±1.52 μg/ml for the aqueous extract composed in equal 
proportions of the aqueous extracts Alchornea cordifolia and 
Antrocaryon klaineanum 75±2.08 for the hydroethanolic acid extract 
composed in equal proportions of the hydroethanolic extracts of 
Alchornea cordifolia and Antrocaryon klaineanum. The two extracts 
have substantially the same activity (p ˃0.05), although different 
from that of acetylsalicylic acid at the p<0.05 threshold. 
Chemical screening 
Table 5 below shows the families of bioactive compounds present in 
the extracts studied: 
  
Table 5: Chemical screening 
Plant Extract Alc. Anth. Anthr. Coum. Flav. Gluc. Phe. Sapo. STS Tan. 
A. cord. Aq. + + + + + + + + + + 
He + + + + + + + + + + 
A. klain. Aq. + - - - + + + + + + 
He + - - - + + + + + + 
Legend: Plant: A. cord: Alchornea cordifolia; A. klain.: Antrocaryon klaineanum; secondary: Secondary metabolites; Anthr.: Anthraquinones; Sapo.: 
Saponins; STS.: Sterols, Terpenoids and Steroids; Flav.: Flavonoids, Alc.: Alkaloids; Coum.: Coumarines; Phe.: Phenols; Tan.: Tannins; Glucosides. 
Extract; aq: aqueous; he: hydroethanolic; (+): presence; (-): absence. 
 
Thus, the compound mainly revealed and present in all the extracts 
are alkaloids, flavonoids, carbohydrates, phenols and tannins. 
DISCUSSION 
The determination of the amount of total phenols content of the two 
extracts recipes previously made showed that the aqueous extract 
(270 mg AAE/g dw) composed extracts of same proportions of 
Alchornea cordifolia and Antrocaryon klaneanum, contained more 
total antioxidants than the hydroethanolic extract (262.41 mg AAE/g 
dw) composed of extracts of same proportions of the two plants. In 
addition, both extracts had statistically the same amount of primary 
antioxidants on the one hand at p = 0.74. On the other hand, the 
aqueous extract (77±1 mg AAE/g dw) was richer than the 
hydroethanolic extract (9.9±1.595 mg AAE/g dw) as antioxidants 
secondary to the threshold of significance (p = 0.0008<0.05). 
The preponderance of secondary antioxidants compared with the 
primary of one of the two extracts studied refers to a preventive role 
in the treatment of diseases caused by oxidative stress and would 
justify the use of these plants in the preventive treatment of a 
pathology that can degenerate into cancer. In several authors 
highlight, the presence in large quantities of secondary antioxidants 
in the ethanolic extracts of leaves and bark of cameroonian plants 
reinforce the use of this plant as indicated in ethnobotany for the 
treatment of breast cancer [33, 29]. 
A kinetic study was carried out before the actual test and it was 
noted that for the two extracts studied, the decay continued until the 
120th minute, the stationary state was still not reached and as 
Nyegue demonstrated in his work on the therapeutic potential of 
essential oils, such kinetics where the plateau is still not reached in 
the 120th minute is said to be slow [27]. The reactivity time of the 
extracts with the DPPH is thus progressive and these extracts could 
act on the long term on the free radicals at the origin of oxidative 
stress. 
Ascorbic acid SC50 was 0.018±0.001 mg/ml and aqueous and 
hydroethanolic extracts 0.047±0.2725 and 0.048±0.8143 mg/ml, 
respectively. In the same time, the aqueous extract alone of 
Alchornea cordifolia reported an EC50 of 0.026 mg/ml [34]; Although 
the recipe showed the ability to trap free radicals, its antiradical 
potential is lower than that of the aqueous extract of Alchornea 
cordifolia, this result reinforces the idea that the combination of 
Nyegue et al. 
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plants in traditional medicine has not always the potentiating effect 
sought for a specific activity. 
The reducing power expressed in mg of Ascorbic acid equivalent per 
g of dry weight of extract was statistically higher in the aqueous 
extract composed in the same proportions of the aqueous extracts of 
Alchornea cordifolia and Antrocaryon klaineanum (70.75±0.34), 
compared to the reducing power of the hydroethanolic extract 
composed of hydroethanolic extracts of the same plant species 
(62.67±0.46) at the significance level p<0.05. Both extracts studied 
demonstrated a good reducing activity of ferric iron. Nevertheless, 
the extracts and Ascorbic acid have statistically different reducing 
capacities at p = 0.0001. Indeed, the reducing capacity of Ascorbic 
Acid (0.53±0.0053 μg/ml) was higher than that of both extracts. 
Furthermore, the reductive capacity of the aqueous extract 
(2.64±0.11 μg/ml) composed in same proportions of the aqueous 
extracts of Alchornea cordifolia and Antrocaryon klaineanum was 
greater than that of the hydroethanolic extract (2.86±0.0655 μg/ml) 
composed in 50: 50 proportions of hydroethanolic extracts of 
Alchornea cordifolia and Antrocaryon klaineanum. An 
ethnobotanical, phytochemical and pharmacological review of 
Alchornea cordifolia has also highlighted its antioxidant properties 
both in vitro and in vivo [35], reinforcing its therapeutic anti-
infective potential. Agbor et al. [33] Report that the extracts of this 
plant have a high antioxidant activity because of their ability to 
reduce iron and to trap free radicals. These results are in harmony 
with those found in the literature that phenolic compounds, most 
especially flavonoids, possess a strong reducing power [36]. 
The denaturation test of Bovine Serum Albumin (BSA) revealed that the 
two extracts studied had substantially the same activity as Diclofenac® 
with an IC50 of 50.21 μg/ml. With respect to the antiproteinase assay, the 
IC50 values obtained ranged from 10±0.57 μg/ml for acetylsalicylic acid 
to 60±1.52 μg/ml for the aqueous extract composed of 50:50 
proportions of extracts aqueous solution of Alchornea cordifolia and 
Antrocaryon klaineanum and 75±2.08 for the hydroethanolic extract 
compound with same proportions of hydroethanolic extracts of the same 
plants. Both extracts had substantially the same activity, although it was 
different from that of Acetylsalicylic acid at p<0.05. The methanolic 
extract of Alchornea cordifolia has, in the past, demonstrated anti-
inflammatory activity [34]. 
Inflammation is the main producer of reactive forms of oxygen, so it 
may be interesting to combine anti-inflammatory treatment with 
antioxidant treatment [37]. Vitamin A, like β-carotene, is a lipophilic 
antioxidant whose role is to protect the body against reactive forms 
of oxygen, and many studies tend to demonstrate their involvement 
in the regulation of inflammation genes [38]. In humans, the addition 
of antioxidants seems, to a certain extent, to have preventive or 
beneficial effects on the evolution of several pathologies [39]. Few 
studies report the effect of antioxidants in equine medicine; 
however, it appears that antioxidants can be used beneficially in 
inflammatory conditions [40]. In addition, as part of the prevention 
of degenerative diseases of the nervous system in horses, it seems 
that vitamin A such as β-carotene are unavoidable elements. 
The chemical screening carried out on the 5 types of plant extracts 
gave an insight into the different groups of metabolites found there. 
Indeed, the compounds present in the aqueous extracts were 
alkaloids, flavonoids, carbohydrates, phenols and tannins. The 
extracts of Alchornea cordifolia are those containing all ten groups of 
secondary metabolites sought. This result is the same as those 
obtained by a large number of studies where Alchornea cordifolia, 
thanks to its wide range of active ingredients, would be used as a 
panacea in several African countries and for the treatment of 
diseases of different orders [41, 35]. In contrast to this study, 
saponins and alkaloids are absent in the aqueous extract of 
Alchornea cordifolia [34]. 
Several factors have been updated to justify the difference in the 
chemical composition of extracts from several individuals of the 
same species; the most incriminated being the place and the period 
of harvest, the treatment suffered by the harvested organ, the mode 
of drying, the nature of the solvents and many others. Chemical 
groups such as flavonoids, polyphenols have been the subject of 
previous studies and the antioxidant and anti-inflammatory 
properties have been recognized; this would justify the use of these 
plants in the treatment of infectious and degenerative diseases [29]. 
CONCLUSION 
Alchornea cordifolia and Antrocaryon klaineanum are two 
cameroonian plants whose virtues have been studied for each one of 
them. These plants whose active compounds are quite diversified 
are used in traditional medicine in the treatment of recurrent 
tropical diseases. In this study, they were associated with the same 
concentrations and their estimated antioxidant and anti-
inflammatory potential. Thus, prepared in two ways, the extracts of 
the same plant revealed the presence of the same bioactive 
compounds. The antioxidant potential evaluated was found to be 
important, although lower than that of the standard molecule. 
Regarding the anti-inflammatory potential of the extracts studied, it 
was identical to that of Diclofenac® thus enhancing their use in the 
management of inflammatory diseases. The anti-inflammatory 
activity of these extracts, which is substantially the same as that of 
Diclofenac® supplemented with their antioxidant potential, would 
be of therapeutic importance for the management of diseases related 
to oxidative stress. 
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